Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib with or without Fosbretabulin in advanced recurrent ovarian cancer
NCT02055690Phase 2Terminated
- Sponsor
- The Christie
- Start
- Sep 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosbretabulin in ovarian cancer, sponsored by The Christie. Started Sep 2014; status: terminated.
02
Drugs
fosbretabulin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02055690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055690.